Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...

Detaylı Bibliyografya
Asıl Yazarlar:	Adam Corey, Nita Johnston
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	University of Minnesota Libraries Publishing 2016-12-01
Seri Bilgileri:	INNOVATIONS in Pharmacy
Konular:	Dronedarone, Amiodarone, Medication Use Evaluation, Atrial Fibrillation
Online Erişim:	https://pubs.lib.umn.edu/index.php/innovations/article/view/480

Benzer Materyaller

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
Yazar:: Li Y, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
Yazar:: Mengran Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
Yazar:: Li-Qin Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2016-05-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
Yazar:: Trigo P, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
Yazar:: M. Yu. Gilyarov, ve diğerleri
Baskı/Yayın Bilgisi: (2010-12-01)

Dronedarone for the management of atrial fibrillation
Yazar:: Swiss Medical Weekly
Baskı/Yayın Bilgisi: (2011-02-01)

Comparative effects of amiodarone and dronedarone treatments on cardiac function in a rabbit model
Yazar:: Worakan Boonhoh, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS
Yazar:: Ye Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics
Yazar:: Ying Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
Yazar:: Christine Benn Christiansen, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
Yazar:: O. V. Gaisenok
Baskı/Yayın Bilgisi: (2016-01-01)

Marked prolongation of QRS duration after initiation of dronedarone therapy
Yazar:: Conrad Genz, ve diğerleri
Baskı/Yayın Bilgisi: (2014-08-01)

Bioavailability of dronedarone tablets administered with or without food in healthy participants
Yazar:: Gerald V. Naccarelli, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone
Yazar:: Yuyan Chen, PM, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Dronedarone for Recurrent Ventricular Tachycardia: A Real Alternative?
Yazar:: Victor Exposito, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2012-03-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
Yazar:: A. G. Pronin, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
Yazar:: O. V. Gaisenok
Baskı/Yayın Bilgisi: (2016-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
Yazar:: Hesham S. Taha, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Dronedarone-induced photoallergic reaction
Yazar:: Levy Amar, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
Yazar:: Niloofar Dadashpour, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
Yazar:: S. Yu. Martsevich, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
Yazar:: Abolfath Alizadeh, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
Yazar:: K. G. Adamyan, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
Yazar:: Nuri Köse, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
Yazar:: Shuxin Hou, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
Yazar:: Mohamed Ali Ahmed, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Transient Bradyarrhythmia A Sole Presentation of Amiodarone-Induced Hypothyroidism
Yazar:: Gautam Jesrani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Amiodarone pulmonary toxicity: Case report
Yazar:: Vasić Nada, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
Yazar:: Daisuke Horiuchi, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2014-06-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
Yazar:: N P Dorofeeva, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
Yazar:: Melissa E. Middeldorp, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Evaluation of Amiodarone Administration in Patients with New-Onset Atrial Fibrillation in Septic Shock
Yazar:: Andreea Oprea, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
Yazar:: D. A. Kuzhel, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Case Report: Amiodarone-induced multi-organ toxicity
Yazar:: Jingrui Yan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
Yazar:: V. A. Sulimov, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Cardiomyocyte-Targeting Peptide to Deliver Amiodarone
Yazar:: Maliha Zahid, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
Yazar:: Kuan-Cheng Lai, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

A case of probable Amiodarone-induced pancreatitis in the treatment of atrial fibrillation: a literature review and case report
Yazar:: Christopher J. Mercogliano, ve diğerleri
Baskı/Yayın Bilgisi: (2017-11-01)

The incidence of phlebitis development of high concentration of continuous amiodarone infusion with in-line filter compared to the low concentration without in-line filter: a retrospective propensity score-matched analysis
Yazar:: Sirichai Cheewatanakornkul, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Local Use of Hydrogel with Amiodarone in Cardiac Surgery: Experiment and Translation to the Clinic
Yazar:: Vladimir Shvartz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)